You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu

News

Coave Therapeutics and ABL link up to develop gene therapy manufacturing processes

Coave Therapeutics – a company focused on treating the central nervous system – and ABL, which specialises in the development of viruses for vaccine candidates, gene and cancer therapies, have entered a strategic collaboration to develop its gene therapy manufacturing processes.